軽度の高尿血症は,塩分感度の高い高血圧と腎臓の損傷を軽減する

Lashodya V Dissanayake¹, Adrian Zietara¹, Ruslan Bohovyk¹

¹Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa. (L.V.D., A.Z., R.B., C.A.K., O.K., V.L., M.L., A. Shapiro, V.P., T.R., A. Staruschenko).

Hypertension (Dallas, Tex. : 1979)

|September 4, 2025

まとめ

軽度の高尿血症 (血中の高尿酸) は,雄のネズミの塩分敏感性高血圧を低下させ,腎臓の損傷を軽減した. この効果はメスラットでは観察されず,尿酸濃度に対する性別の反応を示唆した.

科学分野:

腎臓科
心血管研究
代謝疾患

背景:

無症状の高尿血症は腎臓と心血管の不良の結果と関連しているが,その直接的な役割は議論されている.
食中のナトリウム摂取は尿酸の排泄と相関しており,塩分敏感性高血圧と腎臓損傷に対する高尿血症の影響を暗示しています.
ハイパーウリケミアの影響を理解することは,関連する慢性疾患の管理に不可欠です.

研究の目的:

軽度の高尿血症が塩分敏感性高血圧と腎臓損傷に及ぼす影響をネズミのモデルで調査する.
性別が高尿血症,高血圧,腎臓の結末の関係に影響するかどうかを判断する.
酸化ストレスと血管拡張経路を含む根本的なメカニズムを探求する.

主な方法:

オスと雌のダールSSラットは,高塩分ダイエットまたは高塩分ダイエットだけで3週間,尿酸阻害剤 (オクソン酸) を投与された.
高血圧,腎臓損傷,遺伝子発現を評価するために,放射線計測,免疫ヒストケミストリー,RNA-Seqを用いた.
血尿酸濃度,尿酸排出量,血圧,腎臓縮,酸化ストレスマーカー (8-oxodG),遺伝子発現プロファイルを分析した.

主要な成果:

オクソン酸は両性において血尿酸を有意に増加させたが,尿酸の分泌が増加したのは男性のみであった.
軽度の高尿血症は高血圧の進行を弱め,腎臓の縮とタンパク質の形成を減少させたが,女性ではそうではなかった.
オクソン酸は管の酸化損傷を軽減し,男性腎臓の血管拡張経路遺伝子を高調させた.

結論:

軽度の高尿血症,特に高尿尿症,軽度の塩分感受性高血圧,およびダールSSの雄性ネズミにおける腎臓損傷.
保護効果は性別で,メスラットは同様の効果を示さなかった.
これらの発見は,性差を考慮して,特定の高血圧状態における尿酸濃度の管理に潜在的な役割を果たすことを示唆しています.

キーワード:

動物ダイエット高血圧腎臓ウリック酸

さらに関連する動画

08:08

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta

Published on: June 10, 2015

11.4K

08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

23.8K

関連する概念動画

01:16

Antihypertensive Drugs: Action of Diuretics

869

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...

869

01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

746

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

746

01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

910

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

910

01:25

Antihypertensive Drugs: Direct Renin Inhibitors

817

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

817

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

505

01:18

Hypertension and Regulation of Blood Pressure

3.1K

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...